3 completed, 2 recruiting, 1 active not recruiting. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Recruiting 2, Active not recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Margins of Excision: new trials by email Literature Review of Margins of Excision trials Research Report on Margins of Excision
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors EXS74539 - Solid Tumor, Small Cell Lung Cancer (SCLC) | Phase 1 | Recruiting | Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 40 | 2026-04-13 | 2026-06-10 |
| Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy NeuroSAFE procedure, LaserSAFE procedure - Prostate Cancer | Phase 1 / Phase 2 | Completed | University College, London | 21 | 2024-05-15 | 2025-01-10 |
| B7-H3 NIR Imaging for Osteosarcoma Surgery a targeted probe B7H3-IRDye800CW - Osteosarcoma, Resection Margins | Phase 1 / Phase 2 | Recruiting | Peking University People's Hospital | 32 | 2024-01-01 | 2025-01-16 |
| Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy AIV001 - Keloid, Scar | Phase 1 | Completed | AiViva BioPharma, Inc. | 25 | 2021-06-23 | 2024-12-27 |
| Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer Quality-of-Life Assessment, Questionnaire Administration, Stereotactic Body Radiation Therapy - Lung Non-Small Cell Carcinoma, Positive Surgical Margin | Phase 1 | Active not recruiting | Roswell Park Cancer Institute | 50 | 2019-12-04 | 2026-08-24 |
| A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers CDX-1127 - CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Completed | Celldex Therapeutics | 90 | 2011-10-01 | 2018-01-31 |
Carcinoma, Non-Small-Cell Lung (3) · Carcinoma, Renal Cell (2) · Ovarian Neoplasms (2) · Prostatic Neoplasms (2) · Cicatrix (1) · Keloid (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Mantle-Cell (1) · Melanoma (1) · Osteosarcoma (1) · Small Cell Lung Carcinoma (1)
Morphological and Microscopic Findings (6) · Pathological Conditions, Signs and Symptoms (6) · Neoplasms (5) · Neoplasms by Site (4) · Bronchial Neoplasms (3) · Carcinoma, Bronchogenic (3) · Genital Diseases (3) · Lung Diseases (3) · Male Urogenital Diseases (3) · Neoplasms by Histologic Type (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Skin and Connective Tissue Diseases (3) · Thoracic Neoplasms (3) · Urogenital Diseases (3)
Radiosurgery (1) · varlilumab (1)
AiViva BioPharma, Inc. (1) · Celldex Therapeutics (1) · Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. (1) · Peking University People's Hospital (1) · Roswell Park Cancer Institute (1) · University College, London (1)
United States (4) · China (1) · United Kingdom (1)
Anurag K Singh (1) · Greg Shaw (1)